AC Immune (ACIU) Net Equity Issued and Repurchased (2015 - 2025)
AC Immune (ACIU) posted quarterly Net Equity Issued and Repurchased of -$1251.2 for Q4 2025, down 120.02% quarter-over-quarter from $6250.5 in Q3 2025.
AC Immune (ACIU) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Net Equity Issued and Repurchased for 11 consecutive years, with -$1251.2 the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$1251.2; the TTM figure through Dec 2025 stood at $7893.4 (changed 0.31% YoY), while the FY2025 annual figure was $7236.8, down 9.43% from the prior year.
- Net Equity Issued and Repurchased retreated to -$1251.2 in Q4 2025 per ACIU's latest filing, from $6250.5 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $4.7 million in Q4 2021 and bottomed at -$13272.7 in Q1 2021.
- Historically, Net Equity Issued and Repurchased has averaged $282575.1 across 5 years, with a median of $3357.3 in 2024.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased soared 8881.88% — and 2023, when it sank 699.09%.
- AC Immune's Net Equity Issued and Repurchased stood at $4.7 million in 2021, then tumbled by 99.98% to $1035.5 in 2022, then soared by 444.38% to $5636.8 in 2023, then sank by 79.52% to $1154.2 in 2024, then slumped by 208.4% to -$1251.2 in 2025.
- Business Quant data shows ACIU's Net Equity Issued and Repurchased at -$1251.2 in Q4 2025, $6250.5 in Q3 2025, and $8455.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,251.17 |
| Dec 31, 2025 | -1,251.17 |
| Sep 30, 2025 | 6,250.55 |
| Sep 30, 2025 | 6,250.55 |
| Jun 30, 2025 | 8,455.23 |
| Jun 30, 2025 | 8,455.23 |
| Mar 31, 2025 | -5,561.25 |
| Mar 31, 2025 | -5,561.25 |
| Sep 30, 2024 | 1,154.21 |
| Sep 30, 2024 | 1,154.21 |
| Jun 30, 2024 | 4,423.17 |
| Jun 30, 2024 | 4,423.17 |
| Mar 31, 2024 | 2,291.36 |
| Mar 31, 2024 | 2,291.36 |
| Dec 31, 2023 | 5,636.77 |
| Dec 31, 2023 | 5,636.77 |
| Sep 30, 2023 | 82,647.14 |
| Sep 30, 2023 | 82,647.14 |
| Jun 30, 2023 | -7,785.23 |
| Jun 30, 2023 | -7,785.23 |